We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Diurnal shares more than double on takeover bid

Tue, 30th Aug 2022 11:04

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Diurnal Group PLC, shares surge to 26.19 pence from Friday's close of 11.25p, 12-month range 9.5-67.9p. The pharmaceutical company focused on hormonal diseases agrees to be taken over by Neurocrine Biosciences Inc in deal worth GBP48.3 million. Neurocrine is offering 27.5p, cash, for each Diurnal share. Diurnal directors unanimously recommend deal. "We believe that the acquisition is compelling for Diurnal's shareholders given the risks associated with achieving Diurnal's vision of creating a profitable business, in particular the ongoing commercial roll out of Diurnal's products in Europe and the execution of key clinical studies, in addition to the substantial shareholder dilution that is likely to result from accessing the capital required to deliver this vision," says Non-Executive Chair Anders Harfstrand.

----------

SIMEC Atlantis Energy Ltd, up 31% at 2.03p, 12-month range 0.97p-5.3p. The sustainable energy generation firm secures necessary grid variations for the 230 megawatt/460 megawatt hour battery energy storage system at the Uskmouth site and has completed the novation of the grid connection agreement. "With excellent progress being made, the project is on track to be operational by 2024," it says. Adds it now has no loans outstanding with any SIMEC group company.

----------

MyCelx Technologies Corp, up 14% at 48.36p, 12-month range 30.55p-92.00p. The clean water and air technology firm secures new purchase order from SABIC Agri-Nutrients, a SABIC affiliate, to provide clean water for optimal performance in their fertiliser production process. Also wins short-term emergency response project with a independent petrochemical company in Saudi Arabia and secures renewal of two water treatment contracts with long-standing customers in the Middle East. "These projects underpin the 2022 revenue forecast, and the company remains on track to meet current guidance," it says.

----------

AIM - LOSERS

----------

Petroneft Resources PLC, down 28% at 0.645p, 12-month range 0.65p-4.88p. Reports temporary suspension of oil acceptance and transfer from Licence 61 by Nord Imperial LLC. In 2009, contract was signed with Nord Imperial to cover storage and transfer of oil by pipeline from Licence 61 to the Transneft Entry point at Zavyalovo. Petroneft says it has considered contract tariff to be "significantly higher than normal market rates" for some time. Says payments were made to Nord Imperial at reduced levels amid no progress in finding "more equitable" outcome and, in response, Nord Imperial has temporarily suspending the acceptance of oil and transfer. "As the company currently have no other export route from Licence 61, Petroneft is progressively shutting down its wells until the situation can be resolved," it says.

----------

Joules Group PLC, down 7.5% at 23.58p, 12-month range 19.41p-257.00p. Retailer insists it continues in "positive" discussions with Next over a possible investment, despite Sky News over the weekend reporting that talks had stalled. Sky News said it has learnt the two companies are not close to agreeing the terms of an investment from Next, and the FTSE 100-listed retailer had not received enough financial information to allow it to make a formal offer to the Joules board. There were also doubts that Next would want to proceed with a deal at 33p per share or more given Joules shares closed at 25.5p on Friday. The stock has fallen 82% since the start of 2022, and shares had closed at 33p the day before the companies confirmed they were in talks over the potential equity investment.

----------

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2022 21:18

TRADING UPDATES: SulNOx, Marwyn loss widens; Kropz gets new facility

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
21 Oct 2022 21:29

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
14 Oct 2022 15:48

UK shareholder meetings calendar - next 7 days

Monday 17 October 
Arcontech Group PLCAGM
Barratt Developments PLCAGM
Eight Capital Partners PLCGM re IWEP loan conversion to equity
Tuesday 18 October 
Accrol Group Holdings PLCAGM
Diverse Income TrustAGM
Dolphin Capital Investors LtdAGM
Pantheon International PLCAGM
Tlou Energy LtdAGM
Wednesday 19 October 
Empyrean Energy PLCGM annual report approval
Frasers Group PLCAGM
Hargreaves Lansdown PLCAGM
HydrogenOne Capital Growth PLCGM share issuance programme
Made Tech Group PLCAGM
SME Credit Realisation Fund LtdAGM
Thursday 20 October 
abrdn UK Smaller Companies Growth Trust PLCAGM
Argo Group LtdAGM
Dechra Pharmaceuticals PLCAGM
DX Group PLCGM re 2021 financial year annual report
Gateley Holdings PLCAGM
Science in Sport PLCGM 
Xeros Technology Group PLCGM capital reorganisation
Friday 21 October 
Diurnal Group PLCGM re Neurocrine takeover
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
7 Oct 2022 13:01

Diurnal treatment gets approval from Welsh regulatory body

(Alliance News) - Diurnal Group PLC on Friday said its Efmody treatment has been recommended as an option to treat patients with congenital adrenal hyperplasia.

Read more
7 Oct 2022 11:31

Diurnal's 'Efmody' treatment gets thumbs-up for NHS Wales

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Friday that the All-Wales Medicines Strategy Group (AWMSG) has recommended its 'Efmody' hydrocortisone modified-release hard capsules as an option for restricted use to treat adolescents and adults with congenital adrenal hyperplasia (CAH) within NHS Wales.

Read more
14 Sep 2022 11:40

Diurnal annual loss widens despite revenue growth as costs balloon

(Alliance News) - Diurnal Group PLC on Wednesday reported a widened annual loss as costs, especially on research & development, surged.

Read more
7 Sep 2022 15:53

UK earnings, trading statements calendar - next 7 days

Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Chaarat Gold Holdings LtdHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma Holdings PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
Friday 9 September 
Computacenter PLCHalf Year Results
Creo Medical Group PLCHalf Year Results
Mid Wynd International Investment Trust PLCFull Year Results
Monday 12 September 
ABCAM PLCHalf Year Results
Arcontech Group PLCFull Year Results
Associated British Foods PLCFull Year Results
Greencoat Renewables PLCHalf Year Results
HgCapital Trust PLCHalf Year Results
Kape Technologies PLCHalf Year Results
Made Tech Group PLCFull Year Results
MP Evans Group PLCHalf Year Results
SigmaRoc PLCHalf Year Results
Tirupati Graphite PLCFull Year Results
Tuesday 13 September 
accesso Technology Group PLCHalf Year Results
Churchill China PLCHalf Year Results
Corero Network Security PLCHalf Year Results
Engage XR Holdings PLCHalf Year Results
Facilities by ADF PLCHalf Year Results
Fevertree Drinks PLCHalf Year Results
Futura Medical PLCHalf Year Results
Gateley Holdings PLCFull Year Results
Harworth Group PLCHalf Year Results
HeiQ PLCHalf Year Results
JTC PLCHalf Year Results
Mattioli Woods PLCFull Year Results
Ocado Group PLCTrading Statement
Oxford Nanopore Technologies PLCHalf Year Results
Petra Diamonds LtdFull Year Results
Property Franchise Group PLCHalf Year Results
RBG Holdings PLCHalf Year Results
Smart Metering Systems PLCHalf Year Results
Team17 Group PLCHalf Year Results
Trustpilot Group PLCHalf Year Results
VH Global Sustainable Energy Opportunities PLCHalf Year Results
Wednesday 14 September 
Anpario PLCHalf Year Results
Advanced Medical Solutions Group PLCHalf Year Results
BioPharma Credit PLCHalf Year Results
Blackbird PLCHalf Year Results
Central Asia Metals PLCHalf Year Results
Diurnal Group PLCHalf Year Results
Dunelm Group PLCFull Year Results
Epwin Group PLCHalf Year Results
Glenveagh Properties PLCHalf Year Results
ITM Power PLCFull Year Results
Niox Group PLCHalf Year Results
Pan African Resources PLCFull Year Results
Pharos Energy PLCHalf Year Results
Redrow PLCFull Year Results
Ricardo PLCFull Year Results
STM Group PLCHalf Year Results
Artisanal Spirits Co PLCHalf Year Results
Tullow Oil PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
30 Aug 2022 17:04

LONDON MARKET CLOSE: Stocks move into reverse as pessimism takes over

(Alliance News) - Stocks in London returned from the long weekend on Tuesday to close in the red despite spending most of the session in the green, as investors wiped out the morning's gains following selling pressure in the US.

Read more
30 Aug 2022 14:55

Diurnal to be taken over by Neurocrine Biosciences for £48.3m, shares surge

(Sharecast News) - Diurnal shares surged on Tuesday after it agreed to be taken over by US biotech firm Neurocrine Biosciences for £48.3m.

Read more
30 Aug 2022 12:47

Diurnal shares double on GBP48 million takeover from Neurocrine

(Alliance News) - Diurnal Group PLC on Tuesday said it agreed to a GBP48.3 million takeover from US biopharmaceutical firm Neurocrine Biosciences Inc.

Read more
26 Jul 2022 12:03

IN BRIEF: Diurnal more than doubles product sales in 2022

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says product sales in the year ended June 30, more than doubled to GBP4.6 million from GBP2.3 million the previous year. Revenue in the year totals GBP4.7 million including licensing income of GBP600,000, up from GBP4.4 million the previous year, including licensing income of GBP2.1 million.

Read more
1 Jun 2022 19:41

TRADING UPDATES: Indivior, Diurnal start trials; Alien Metals tests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
9 May 2022 14:01

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

Read more
25 Apr 2022 19:19

IN BRIEF: Diurnal expands distribution agreement with EffRx

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Extends distribution and marketing agreement with EffRx Pharmaceuticals in Switzerland to include Efmody.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.